Leukemia Cells Are "Bad To The Bone"
Links shared publicly online about this topic.
- 0total visits
Leukemia Cells Are "Bad To The Bone"
View full resource at medicalnewstoday.com
Tags: Cancer, Leukemia, Lymphoma, Bone, Medical
Most Recently Shared on January 30, 2012 at 8:05 am By:
Leukemia Cells Are "Bad To The Bone" http://t.co/H2JT3YpJ #bones #orthopedics
Also Shared By:
New form and function of a key protein - National Cancer Institute
cancer.gov — “Research led by St. Jude Children’s Research Hospital investigators suggests that safeguarding cell survival and maintaining a balanced immune system is just the start of the myeloid cell leukemia sequence 1 (MCL1) protein’s work. Nearly 20 years after MC” View full resource at cancer.gov
Most Recently Shared on May 1, 2012 at 7:36 pm By:
Scientists at @StJude discover new form & function of a key protein that may provide a novel #cancer treatment target http://t.co/22W3HOTY
Leukaemia Cells Have A Remembrance Of Things Past
medicalnewstoday.com — “Although people generally talk about cancer, it is clear that the disease occurs in a bewildering variety of forms. Even single groups of cancers, such as those of the white blood cells, may sho” View full resource at medicalnewstoday.com
Most Recently Shared on April 26, 2012 at 8:05 am By:
MNT Veterinary News Health News
Leukaemia Cells Have A Remembrance Of Things Past http://t.co/IZ3zL7D8 #veterinary
Penn Medicine Cancer Team's "Serial Killer" T Cell Leukemia Treatment Named Among Nation's Top Clinical Research Achievements
uphs.upenn.edu — “Carl June, MD, director of Translational Research for the Abramson Cancer Center and a professor of Pathology and Laboratory Medicine in the Perelman School of Medicine at University of Pennsylvania, has been named among the top three winners of the inaugural Clinical Research Forum Top 10 Clinical Research Achievement Awards for his work treating chronic lymphocytic leukemia using genetically engineered versions of patients' own T cells, which multiply in the body as” View full resource at uphs.upenn.edu
Most Recently Shared on April 23, 2012 at 1:53 pm By:
ASH Hematology and Health Organization
@Pennmedicine "Serial Killer" T Cell #Leukemia Treatment Named Among Nations Top Clinical #Research Achievements http://t.co/jKBQDE7c
'Addiction' Of Leukemia Cells Exploited In New Therapy
medicalnewstoday.com — “A new study describes a therapeutic approach to halting cancer progression by exploiting a previously unrecognized addiction of leukemia cells to specific signaling molecules. The research, publ” View full resource at medicalnewstoday.com
Most Recently Shared on April 17, 2012 at 9:05 am By:
'Addiction' Of Leukemia Cells Exploited In New Therapy http://t.co/BT1MOFxt #genetics
An Evening with the CML Experts?
events.r20.constantcontact.com — “Many new therapeutic advances are soon to be available for those living with CML. These advances include those that will further address mutations, as well as the eradication of Leukemic Stem Cells that could eventually lead to a cure for CML. This event is designed to introduce you to these emerging therapies! One you won't want to miss!” View full resource at events.r20.constantcontact.com
Most Recently Shared on April 17, 2012 at 12:05 am By:
JanCerny, MD, PhD Hematologist, Physician, Doctor, PhD, Internist, and Oncologist
Did you register? at the National #CML Society for "An Evening with the CML Experts™" from @umassmemorial, April 26th. http://t.co/ueMlMkqz
St. Jude Children's Research Hospital | St. Jude Tribute
fundraising.stjude.org — “St. Jude Children's Research Hospital is internationally recognized for its pioneering work in finding cures and saving children with pediatric cancer and other catastrophic diseases. Founded by late entertainer Danny Thomas and located in Memphis, Tennessee, St. Jude is the premiere institution for treating such life-threatening illnesses as leukemia, brain tumors, solid tumors, sickle cell disease, osteogenesis imperfecta (OI) and other childhood infectious diseases. All St. Jude treatment pro” View full resource at fundraising.stjude.org
Most Recently Shared on March 28, 2012 at 2:05 pm By:
St. Jude Hospital and Children's Hospital
Issac's family met their #Hoops4StJude Week goal! Please help them double their goal in Isaac's honor by Friday: http://t.co/JhmI0RZx
Molecular Cancer | Abstract | RhoA: A therapeutic target for chronic myeloid leukemia
molecular-cancer.com — “Chronic Myeloid Leukemia (CML) is a malignant pluripotent stem cells disorder of myeloid cells. In CML patients, polymorphonuclear leukocytes (PMNL) the terminally differentiated cells of myeloid series exhibit defects in several actin dependent functions such as adhesion, motility, chemotaxis, agglutination, phagocytosis and microbicidal activities. A definite and global abnormality was observed in stimulation of actin polymerization in CML PMNL. Signalling molecules ras and rhoGTPases regulate” View full resource at molecular-cancer.com
Most Recently Shared on March 26, 2012 at 12:30 pm By:
BioMed Central Medical Journal
RhoA: A therapeutic target for chronic myeloid #leukemia http://t.co/Uetq102X research from #MolecularCancer #cancer
Cancer Cells Reprogrammed With Low Doses Of Epigenetic Drugs
medicalnewstoday.com — “Experimenting with cells in culture, researchers at the Johns Hopkins Kimmel Cancer Center have breathed possible new life into two drugs once considered too toxic for human cancer treatment. The” View full resource at medicalnewstoday.com
Most Recently Shared on March 26, 2012 at 7:05 am By:
Cancer Cells Reprogrammed With Low Doses Of Epigenetic Drugs http://t.co/dj68HJMj #lymphoma #leukemia
Drug makes leukemia more vulnerable to chemo
labspaces.net — “Doctors at Washington University School of Medicine in St. Louis have shown that a new drug makes chemotherapy more effective in treating acute myeloid leukemia, a cancer of the white blood cells. Instead of attacking these cells directly, the drug helps drive them out of the bone marrow and into the bloodstream, where they are more vulnerable to chemotherapy.” View full resource at labspaces.net
Most Recently Shared on March 21, 2012 at 1:00 pm By:
Drug makes leukemia more vulnerable to chemo - http://t.co/FOdCqvTJ
Plerixafor Makes Leukemia More Vulnerable To Chemo
medicalnewstoday.com — “Doctors at Washington University School of Medicine in St. Louis have shown that a new drug makes chemotherapy more effective in treating acute myeloid leukemia, a cancer of the white blood cells.” View full resource at medicalnewstoday.com
Most Recently Shared on March 21, 2012 at 8:05 am By:
Plerixafor Makes Leukemia More Vulnerable To Chemo http://t.co/ee2DCo8l #lymphoma #leukemia
Drug makes leukemia more vulnerable to chemo
eurekalert.org — “Doctors at Washington University School of Medicine in St. Louis have shown that a new drug makes chemotherapy more effective in treating acute myeloid leukemia, a cancer of the white blood cells. Instead of attacking these cells directly, the drug helps drive them out of the bone marrow and into the bloodstream, where they are more vulnerable to chemotherapy.” View full resource at eurekalert.org
Most Recently Shared on March 20, 2012 at 2:40 pm By:
Drug makes leukemia more vulnerable to chemo: ( Washington University School of Medicine ) Doctors at Washington... http://t.co/xR7D9iPm
Drug Makes Leukemia More Vulnerable to Chemo
newswise.com — “Doctors at Washington University School of Medicine in St. Louis have shown that a new drug makes chemotherapy more effective in treating acute myeloid leukemia, a cancer of the white blood cells. Instead of attacking these cells directly, the drug helps drive them out of the bone marrow and into the bloodstream, where they are more vulnerable to chemotherapy.” View full resource at newswise.com
Most Recently Shared on March 20, 2012 at 1:50 pm By:
#health news: Drug Makes Leukemia More Vulnerable to Chemo http://t.co/H5JY1lRU
Drug makes leukemia more vulnerable to chemo
medicalxpress.com — “(Medical Xpress) -- Doctors at Washington University School of Medicine in St. Louis have shown that a new drug makes chemotherapy more effective in treating acute myeloid leukemia, a cancer of the white blood cells. Instead of attacking these cells directly, the drug helps drive them out of the bone ...” View full resource at medicalxpress.com
Most Recently Shared on March 20, 2012 at 10:58 am By:
PhysOrg Health News Health News
Drug makes leukemia more vulnerable to chemo http://t.co/WHBuhfwX
30% Of Patients With Non Small Cell Lung Cancer Present Alterations In BRG1
medicalnewstoday.com — “Retinoic acid (vitamin A) and steroids are hormones found in our body that protect against oxidative stress, reduce inflammation and are involved in cellular differentiation processes. One of the” View full resource at medicalnewstoday.com
Most Recently Shared on March 19, 2012 at 7:05 am By:
30% Of Patients With Non Small Cell Lung Cancer Present Alterations In BRG1 http://t.co/7f8OW8fM #prostate
Infectious Disease News - Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib |3982529
mdlinx.com — “Infectious Disease Medical Article: Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib” View full resource at mdlinx.com
Most Recently Shared on March 17, 2012 at 3:39 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by d... http://t.co/Mt0FHlEd #ID
Advertisement
MNT Leukemia
@mnt_leukemia
30% Of Patients With Non Small Cell Lung Cancer Present Alterations In BRG1 http://t.co/e0SzZLxo #lymphoma #leukemia
1 year ago...